1-7 of 7
Gabriella Zupi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents

Annamaria Biroccio, Manuela Porru, Angela Rizzo, Erica Salvati, Carmen D'Angelo, Augusto Orlandi, Daniela Passeri, Marco Franceschin, Malcolm F.G. Stevens, Eric Gilson, Giovanni Beretta, Gabriella Zupi, Claudio Pisano, Franco Zunino, Carlo Leonetti
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2227–2236.
https://doi.org/10.1158/1078-0432.CCR-10-3033
Published: 14 April 2011
View article titled, DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents
Open the PDF for DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents in another window
Includes: Supplementary data
Journal Articles

G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors

Carlo Leonetti, Marco Scarsella, Giuseppe Riggio, Angela Rizzo, Erica Salvati, Maurizio D'Incalci, Lidia Staszewsky, Roberta Frapolli, Malcolm F. Stevens, Antonella Stoppacciaro, Marcella Mottolese, Barbara Antoniani, Eric Gilson, Gabriella Zupi, Annamaria Biroccio
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7284–7291.
https://doi.org/10.1158/1078-0432.CCR-08-0941
Published: 14 November 2008
View article titled, G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors
Open the PDF for G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors in another window
Journal Articles

Antitumor Efficacy of bcl-2 and c-myc Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence

Gabriella Zupi, Marco Scarsella, Sean C. Semple, Marcella Mottolese, Pier G. Natali, Carlo Leonetti
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (5): 1990–1998.
https://doi.org/10.1158/1078-0432.CCR-04-1284
Published: 08 March 2005
View article titled, Antitumor Efficacy of <em>bcl-2</em> and <em>c-myc</em> Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence
Open the PDF for Antitumor Efficacy of <em>bcl-2</em> and <em>c-myc</em> Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence in another window
Journal Articles

pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol

Tiziana Tonini, Chiara Gabellini, Luigi Bagella, Giuseppina D’Andrilli, Valeria Masciullo, Gaetano Romano, Giovanni Scambia, Gabriella Zupi, Antonio Giordano
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 8085–8093.
https://doi.org/10.1158/1078-0432.CCR-04-0996
Published: 07 December 2004
View article titled, pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol
Open the PDF for pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol in another window
Journal Articles

Trastuzumab Down-Regulates Bcl-2 Expression and Potentiates Apoptosis Induction by Bcl-2/Bcl-XL Bispecific Antisense Oligonucleotides in HER-2 Gene–Amplified Breast Cancer Cells

Michele Milella, Daniela Trisciuoglio, Tiziana Bruno, Ludovica Ciuffreda, Marcella Mottolese, Anna Cianciulli, Francesco Cognetti, Uwe Zangemeister-Wittke, Donatella Del Bufalo, Gabriella Zupi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7747–7756.
https://doi.org/10.1158/1078-0432.CCR-04-0908
Published: 29 November 2004
View article titled, Trastuzumab Down-Regulates Bcl-2 Expression and Potentiates Apoptosis Induction by Bcl-2/Bcl-X<sub>L</sub> Bispecific Antisense Oligonucleotides in <em>HER-2</em> Gene–Amplified Breast Cancer Cells
Open the PDF for Trastuzumab Down-Regulates Bcl-2 Expression and Potentiates Apoptosis Induction by Bcl-2/Bcl-X<sub>L</sub> Bispecific Antisense Oligonucleotides in <em>HER-2</em> Gene–Amplified Breast Cancer Cells in another window
Journal Articles

Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma

Lucio Tentori, Carlo Leonetti, Marco Scarsella, Giulia d’Amati, Matteo Vergati, Ilaria Portarena, Weizheng Xu, Vincent Kalish, Gabriella Zupi, Jie Zhang, Grazia Graziani
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5370–5379.
Published: 12 November 2003
View article titled, Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma
Open the PDF for Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma in another window
Journal Articles

Increase of Cisplatin Sensitivity by c-myc Antisense Oligodeoxynucleotides in a Human Metastatic Melanoma Inherently Resistant to Cisplatin

Carlo Leonetti, Annamaria Biroccio, Antonio Candiloro, Gennaro Citro, Cristina Fornari, Marcella Mottolese, Donatella Del Bufalo, Gabriella Zupi
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2588–2595.
Published: 01 September 1999
View article titled, Increase of Cisplatin Sensitivity by c-<em>myc</em> Antisense Oligodeoxynucleotides in a Human Metastatic Melanoma Inherently Resistant to Cisplatin
Open the PDF for Increase of Cisplatin Sensitivity by c-<em>myc</em> Antisense Oligodeoxynucleotides in a Human Metastatic Melanoma Inherently Resistant to Cisplatin in another window